← back to search

Can Zhang

Weifang Medical University · CN
Area of research
Biomaterials · Molecular Biology
Research interest
Research interests include Nanoparticle-Based Drug Delivery, RNA Interference and Gene Delivery, Nanoplatforms for cancer theranostics, and Chronic Lymphocytic Leukemia Research.
h-index
65
citations
14,964
works
459
NIH funding
primary concept
Medicine
email

Recent publications

Design, Synthesis, and Investigation of Anti-liver Fibrosis Activity of Steroidal VDR Modulators via Side-Chain Modifications.
2026cited by 0position: contributordoi
Glycolic acid application reduces the browning of taro slices by diminishing ROS level and membrane lipid metabolism
Food Chemistry 2025cited by 6position: middledoi
Sialyltransferase-related genes as predictive factors for therapeutic response and prognosis in cervical cancer
PeerJ 2025cited by 1position: middledoi
Design, Synthesis, and Evaluation of Antifibrotic Activity of Nonsteroidal VDR Agonists Featuring 1,6-Naphthol as a CD-Ring Surrogate.
2025cited by 0position: contributordoi
Effective RNA Delivery with Aggregation-Induced Lipid Backfolding.
2025cited by 0position: contributordoi
Call for Papers: Pharmaceutical Innovation and Global Health: Breakthroughs and Future─Celebrating the 90th Anniversary of China Pharmaceutical University
Journal of Medicinal Chemistry 2025cited by 0position: contributordoi
Enhancing Glioblastoma Immunotherapy with Integrated Chimeric Antigen Receptor T Cells through the Re-Education of Tumor-Associated Microglia and Macrophages.
2024cited by 19position: contributordoi
Clonal Hematopoiesis in Patients with Chronic Lymphocytic Leukemia Treated with Fixed-Duration Venetoclax-Obinutuzumab or Chlorambucil-Obinutuzumab: Insights from the Randomized CLL14 Trial
Blood 2024cited by 5position: middledoi
Preparation of magnetic cationic Schiff base polymeric material for highly selective enrichment of avermectins from surface water and milk samples
Journal of Chromatography A 2024cited by 5position: firstdoi
Photoactivated Formation of an Extravascular Dynamic Hydrogel as an Intelligent Blood Flow Regulator to Reprogram the Immunogenic Landscape.
2024cited by 4position: contributordoi
Small-Molecule Therapeutics Achieve Multiple Mechanism-Mediated Sensitizations of Colorectal Cancer to Immune Checkpoint Blockade via Neutrophil Micropharmacies.
2024cited by 2position: contributordoi
Spatiotemporally Controlled T-Cell Combination Therapy for Solid Tumor.
2024cited by 2position: contributordoi
Sensitizing Tumors to Immune Checkpoint Blockage via STING Agonists Delivered by Tumor-Penetrating Neutrophil Cytopharmaceuticals.
2023cited by 52position: contributordoi
A Photolabile Curcumin‐Diazirine Analogue Enables Phototherapy with Physically and Molecularly Produced Light for Alzheimer's Disease Treatment**
Angewandte Chemie International Edition 2023cited by 40position: middledoi
Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers.
2023cited by 24position: contributordoi
Synergistic Apoptosis-Ferroptosis: Oxaliplatin loaded amorphous iron oxide nanoparticles for High-efficiency therapy of orthotopic pancreatic cancer and CA19-9 levels decrease
Chemical Engineering Journal 2023cited by 17position: middledoi
Vitamin D receptor (VDR) mediates the quiescence of activated hepatic stellate cells (aHSCs) by regulating M2 macrophage exosomal smooth muscle cell-associated protein 5 (SMAP-5)
Journal of Zhejiang University-SCIENCE B 2023cited by 13position: contributordoi
Discovery of novel tumor-targeted near-infrared probes with 6-substituted pyrrolo[2,3-d]pyrimidines as targeting ligands
European Journal of Medicinal Chemistry 2023cited by 7position: middledoi
Neutrophil Cyto-Pharmaceuticals Suppressing Tumor Metastasis via Inhibiting Hypoxia-Inducible Factor-1α in Circulating Breast Cancer Cells.
2022cited by 22position: contributordoi
Single-component lipid nanoparticles for engineering SOCS1 gene-silenced dendritic cells to boost tumor immunotherapy.
2022cited by 6position: contributordoi
Biomarkers of related driver genes predict anti-tumor efficacy of immune checkpoint inhibitors
Frontiers in Immunology 2022cited by 3position: middledoi
A neutrophil-mimetic magnetic nanoprobe for molecular magnetic resonance imaging of stroke-induced neuroinflammation
Biomaterials Science 2021cited by 36position: contributordoi
Protein corona-guided tumor targeting therapy <i>via</i> the surface modulation of low molecular weight PEG
Nanoscale 2021cited by 28position: contributordoi
Survival of patients with chronic lymphocytic leukemia before and after the introduction of chemoimmunotherapy in Germany
Blood Cancer Journal 2021cited by 22position: middledoi
Poly-β-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis.
2021cited by 20position: contributordoi
Novel Nonsecosteroidal Vitamin D Receptor Modulator Combined with Gemcitabine Enhances Pancreatic Cancer Therapy through Remodeling of the Tumor Microenvironment.
2021cited by 20position: contributordoi
Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial
The Lancet Oncology 2020cited by 325position: middledoi
Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax
Blood 2020cited by 126position: middledoi
Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy.
2020cited by 122position: contributordoi
Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment
Carbohydrate Polymers 2020cited by 72position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 29 papers (2019–2026)Michael Hallek · Max Planck Institute for the Study of Societies3 papers (2020–2024)Karl-Anton Kreuzer · University of Cologne2 papers (2020–2024)Hongbin Sun · Union Hospital2 papers (2020–2025)Hongyan Qian · Nantong University2 papers (2019–2019)Yanwen Jiang · University College London2 papers (2020–2024)Stephan Stilgenbauer · Spital STS2 papers (2020–2024)Eugen Tausch · Ludwig-Maximilians-Universität München2 papers (2020–2024)Weiling Zhang · Shandong University of Technology2 papers (2019–2019)Aiqin He · Nantong University2 papers (2019–2025)Lars Bullinger · University of Gothenburg2 papers (2020–2024)Anna‐Maria Fink · Düsseldorf University Hospital2 papers (2020–2021)Kirsten Fischer · Ludwig-Maximilians-Universität München2 papers (2020–2024)Sandra Robrecht · University of Cologne2 papers (2020–2024)Matthias Ritgen · University Hospital Schleswig-Holstein2 papers (2020–2024)Rui Ji · Shandong University2 papers (2019–2019)Othman Al‐Sawaf · Integrated Oncology (United States)2 papers (2020–2024)Christof Schneider · Universität Ulm2 papers (2020–2024)Barbara Eichhorst · Okayama University Hospital2 papers (2020–2024)Yong Li · Nanchang University2 papers (2019–2019)